Search results for "release"

showing 10 items of 602 documents

CURCUMIN ENTRAPPED INTO LIPID NANOSYSTEMS IMPROVES INHIBITION OF NEUROBLASTOMA CANCER CELL GROWTH ACTIVATING HSP70 PROTEIN

2010

Nanostructured Lipid Carriers Curcumin Drug release Human neuroblastoma cells Hsp70 protein CancerSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

Nanohydrogel Formation within the Halloysite Lumen for Triggered and Sustained Release

2018

An easy strategy to obtain nanohydrogels within the halloysite nanotube (HNTs) lumen was investigated. Inorganic reverse micelles based on HNTs and hexadecyltrimethylammonium bromides were dispersed in chloroform, and the hydrophilic cavity was used as a nanoreactor to confine the gel formation based on alginate cross-linked by calcium ions. Spectroscopy and electron microscopy experiments proved the confinement of the polymer into the HNT lumen and the formation of calcium-mediated networks. Biological tests proved the biocompatibility of the hybrid hydrogel. The nanogel in HNTs was suitable for drug loading and sustained release with the opportunity of triggered burst release by chemical …

NanotubeMaterials scienceBiocompatibilityChlorine compound02 engineering and technologyNanoreactorHexadecyl trimethyl ammonium bromideengineering.materialHybrid hydrogel010402 general chemistry01 natural sciencesMicelleHalloysiteSustained release Drug deliveryAdsorptionKaoliniteHalloysite nanotube (HNTs)Chemical stimuliGeneral Materials ScienceControlled drug deliveryBiological testSettore CHIM/02 - Chimica Fisicachemistry.chemical_classificationTargeted drug deliveryCrosslinkingReverse micellePolymer021001 nanoscience & nanotechnology0104 chemical sciencesChemical engineeringchemistryYarn Biological applicationengineeringBiocompatibilityCalcium0210 nano-technologyMicelleNanogelACS Applied Materials & Interfaces
researchProduct

Halloysite Nanotubes: Controlled Access and Release by Smart Gates

2017

© 2017 by the authors. Licensee MDPI, Basel, Switzerland. Hollow halloysite nanotubes have been used as nanocontainers for loading and for the triggered release of calcium hydroxide for paper preservation. A strategy for placing end-stoppers into the tubular nanocontainer is proposed and the sustained release from the cavity is reported. The incorporation of Ca(OH) 2 into the nanotube lumen, as demonstrated using transmission electron microscopy (TEM) imaging and Energy Dispersive X-ray (EDX) mapping, retards the carbonatation, delaying the reaction with CO 2 gas. This effect can be further controlled by placing the end-stoppers. The obtained material is tested for paper deacidification. We…

NanotubeMaterials scienceGeneral Chemical EngineeringCarbonation02 engineering and technologyengineering.material010402 general chemistry01 natural sciencesHalloysiteArticlelcsh:Chemistrychemistry.chemical_compoundControlled releaseGeneral Materials ScienceComposite materialCelluloseSettore CHIM/02 - Chimica FisicaNanocompositeNanocompositeCalcium hydroxideNanocontainerHalloysiteCellulose; Controlled release; Halloysite; Nanocomposite021001 nanoscience & nanotechnologyControlled release0104 chemical scienceslcsh:QD1-999chemistryCarbonatationengineeringhalloysite; nanocomposite; cellulose; controlled release0210 nano-technologyNanomaterials
researchProduct

Halloysite Nanotube with Fluorinated Lumen: Non-Foaming Nanocontainer for Storage and Controlled Release of Oxygen in Aqueous Media

2014

Halloysite clay nanotubes were selectivity modified by adsorbing perfluoroalkylated anionic surfactants at the inner surface. The modified nanotubes formed kinetically stable dispersions due to the enhanced electrostatic repulsions exercised between the particles. We proved that the modified nanotubes can be used as non-foaming oxygen nanocontainers in aqueous media. The gas release from supersaturated dispersions can be controlled by external stimuli and system composition. In conclusion, we managed to put forward an easy strategy to develop smart materials from natural nanoclays, which can endow important applications like the storage and delivery of gas.

NanotubeMaterials sciencechemistry.chemical_elementengineering.materialSmart materialHalloysiteOxygenBiomaterialsCondensed Matter::Materials ScienceFluorinated surfactantColloid and Surface ChemistryHalloysite; nanoclay; Fluorinated surfactant; Gas solubilizationOrganic chemistryPhysics::Chemical PhysicsComputer Science::DatabasesSettore CHIM/02 - Chimica FisicaSupersaturationNanocontainerHalloysiteControlled releaseSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsCondensed Matter::Soft Condensed MatternanoclaychemistryChemical engineeringengineeringGas solubilizationSelectivity
researchProduct

Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids

2013

Objectives: The aim of this exploratory study was to assess the conversion ratios between tapentadol and other opioids in patients requiring an opioid switching. Methods: A prospective study was carried out in a convenience sample of consecutive patients admitted to an acute palliative care unit and a home care unit for a period of 1 year. Patients who were switched from/to tapentadol were selected. The initial ratio between tapentadol and other opioids, expressed as oral morphine equivalents was 1:3.3. The subsequent doses were flexible and were changed to fit the patients’ needs. Pain intensity and distress score were recorded until opioid doses were stable. In all, 37 patients were exami…

NarcoticsPalliative careReceptors Opioid muPainSettore MED/41 - AnestesiologiaOpioidPhenolsNeoplasmsReceptorsmedicineHumansIn patientProspective StudiesCancer painProspective cohort studyConversion ratioAnalgesicsMorphinebusiness.industryMedicine (all)Palliative CareCancerGeneral MedicineTapentadolmedicine.diseaseAnalgesics OpioidTapentadolOpioidmuDelayed-Action PreparationsAnesthesiaCancer pain; Conversion ratio; Opioid switching; Tapentadol; Analgesics Opioid; Delayed-Action Preparations; Humans; Morphine; Narcotics; Neoplasms; Pain; Palliative Care; Phenols; Prospective Studies; Receptors Opioid mu; Medicine (all)Opioid switchingExtended releasebusinessCancer painCancer pain Conversion ratio Opioid switching Tapentadol Analgesiamedicine.drugCurrent Medical Research and Opinion
researchProduct

Slow release oral morphine versus methadone for the treatment of opioid use disorder

2019

ObjectiveTo assess the efficacy of slow release oral morphine (SROM) as a treatment for opioid use disorder (OUD).DesignSystematic review and meta-analysis of randomised controlled trials (RCTs).Data sourcesThree electronic databases were searched through 1 May 2018: the Cochrane Central Register of Controlled Trials, MEDLINE and EMBASE. We also searched the following electronic registers for ongoing trials: ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, Current Controlled Trials and the EU Clinical Trials Register.Eligibility criteria for selecting studiesWe included RCTs of all durations, assessing the effect of SROM on measures of treatment retention, heroin use…

Narcoticsmedicine.medical_specialtyAddictionAdministration OralCraving1681substance use treatmentHeroin03 medical and health sciences0302 clinical medicineSlow release oral morphine (SROM)Internal medicineOpiate Substitution TreatmentHumansMedicine1506030212 general & internal medicine10. No inequalityAdverse effectRandomized Controlled Trials as TopicMorphinebusiness.industryResearchsubstance misuseopioid use disorderOpioid use disorderGeneral MedicineOpioid-Related Disordersmedicine.disease3. Good healthmeta-analysisClinical trialoral morphineOpioid use disorderReducing heroin useDelayed-Action PreparationsMeta-analysisRelative riskmedicine.symptombusinessMethadone030217 neurology & neurosurgerymedicine.drugMethadoneBMJ Open
researchProduct

Microencapsulation of antioxidant compounds through innovative technologies and its specific application in meat processing

2018

Background Meat has a complex physical structure and chemical composition that is very prone to oxidation. Plants are sources of biologically active compounds (antioxidants) of interest as potential raw materials for meat processing, primary as replacements for synthetic additives. Some examples are essential oils from aromatic plants that are usually unstable under common processing and storage conditions and exhibit strong smell and off flavour. Hence, stable delivery systems like encapsulation are required. Scope and approach Encapsulation, and particularly spray-drying, offers protection of active compounds, their controlled and targeted release in food products and ability to mask unac…

Natural antioxidants ; Meat processing ; Encapsulation ; Wall materials ; Spray-drying ; NanotechnologyMeat packing industryOff-flavourComputer sciencebusiness.industrySpray-dryingAromatic plants04 agricultural and veterinary sciencesNatural antioxidantsRaw materialMeat processing040401 food scienceWall material0404 agricultural biotechnologyPhysical structureWall materialsFood productsNanotechnologyEncapsulationBiochemical engineeringbusinessTargeted releaseFood ScienceBiotechnology
researchProduct

Investigation of hydrogen and deuterium impact on the release of tritium from two-phase lithium ceramics under reactor irradiation

2022

In the development of fusion energy, an important task is the study and improvement of tritium production technologies. In this case, one of the most promising materials for tritium generation is lithium ceramics. Considering the importance of the task, numerous studies are aimed at solving the problem of determining the parameters and mechanisms of tritium release in lithium-containing materials. This paper presents the results of a study of tritium release processes from two-phase lithium ceramics of Li$_{4}$SiO$_{4}$/Li$_{2}$TiO$_{3}$ during reactor irradiation when hydrogen and deuterium are injected into the chamber with irradiated samples. The mechanisms regularities of the tritium yi…

Neutron irradiationTechnologyTritium releaseNuclear and High Energy PhysicsNuclear Energy and EngineeringMaterials Science (miscellaneous)TK9001-9401Nuclear engineering. Atomic powerTritiumDeuteriumddc:600Two-phase lithium ceramicNuclear Materials and Energy
researchProduct

Characterization of neutrophil subsets in healthy human pregnancies

2014

We have previously shown that in successful pregnancies increased arginase activity is a mechanism that contributes to the suppression of the maternal immune system. We identified the main type of arginase-expressing cells as a population of activated low-density granulocytes (LDGs) in peripheral blood mononuclear cells and in term placentae. In the present study, we analyzed the phenotype of LDGs and compared it to the phenotype of normal density granulocytes (NDGs) in maternal peripheral blood, placental biopsies and cord blood. Our data reveal that only LDGs but no NDGs could be detected in placental biopsies. Phenotypically, NDGs and LDGs from both maternal and cord blood expressed diff…

NeutrophilsPlacentaEnzyme Metabolismlcsh:MedicineGene ExpressionBiochemistryCell DegranulationNeutrophil ActivationImmune toleranceLeukocyte Count0302 clinical medicineImmunophenotypingPregnancyMolecular Cell BiologySUPPRESSOR-CELLSlcsh:Science0303 health scienceseducation.field_of_studyMultidisciplinaryL-ARGININEObstetrics and GynecologyFetal BloodInnate Immunity3. Good healthEnzymesmedicine.anatomical_structurePhenotypeARGINASE ACTIVITYCord bloodMedicineScience & Technology - Other TopicsFemaleBiological MarkersTHERAPEUTIC PERSPECTIVESResearch ArticleEXPRESSIONAdultCordGeneral Science & TechnologyImmune CellsPopulationImmunologyBiologyMETABOLISMGRANULOCYTESGPI-Linked ProteinsPeripheral blood mononuclear cellMECHANISMSImmunophenotyping03 medical and health sciencesImmune systemAntigens CDPlacentaMD MultidisciplinarymedicineImmune ToleranceHumansCell LineageeducationBiology030304 developmental biologyScience & TechnologyArginaseMULTIDISCIPLINARY SCIENCESlcsh:RImmunityOXIDANT RELEASEImmunologyWomen's Healthlcsh:QClinical ImmunologyIMMUNE-SYSTEMCell Adhesion MoleculesCytometryBiomarkers030215 immunology
researchProduct

Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells

2015

Here, the potential of two nanostructured lipid carriers (NLC) for controlled release of sorafenib was evaluated. The obtained systems showed characteristics suitable as drug delivery systems for the treatment of hepatocellular carcinoma (HCC) through parenteral administration. The use of a mixture between a solid lipid (tripalmitin) with a liquid lipid (Captex 355 EP/NF or Miglyol 812) to prepare NLC systems could give a higher drug loading capacity and a longer term stability during storage than that obtained by using only solid lipids. The obtained nanoparticles showed a nanometer size and high negative zeta potential values. Scansion electron microscopy (SEM) of the sorafenib loaded NLC…

NiacinamideSorafenibDrugCell Survivalmedia_common.quotation_subjectnanostructured lipid carriersPharmaceutical ScienceAntineoplastic AgentsPharmacologyHemolysischemistry.chemical_compoundNanostructured lipid carriers Sorafenib Drug release Angiogenesis inhibitor HepatocarcinomamedicineZeta potentialHumansParticle SizeChromatography High Pressure LiquidTriglyceridesdrug releasemedia_commonDrug CarriersPhenylurea CompoundsHep G2 Cellsmedicine.diseaseLipidsControlled releasedigestive system diseasesIn vitroDrug Liberationangiogenesis inhibitorchemistryhepatocarcinomaSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDelayed-Action PreparationsHepatocellular carcinomaTripalmitinDrug deliveryMicroscopy Electron ScanningNanoparticlessorafenibCaprylatesmedicine.drug
researchProduct